Article Versions Notes

Gwin WR III, Salazar LG, Dai JY, Higgins D, Coveler AL, Childs JS, Blancas R, Dang Y, Reichow J, Slota M, et al. A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer. Vaccines. 2025; 13(2):117. https://doi.org/10.3390/vaccines13020117

Gwin, William R., III, Lupe G. Salazar, James Y. Dai, Doreen Higgins, Andrew L. Coveler, Jennifer S. Childs, Rosie Blancas, Yushe Dang, Jessica Reichow, Meredith Slota, and et al. 2025. "A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer" Vaccines 13, no. 2: 117. https://doi.org/10.3390/vaccines13020117

Gwin, W. R., III, Salazar, L. G., Dai, J. Y., Higgins, D., Coveler, A. L., Childs, J. S., Blancas, R., Dang, Y., Reichow, J., Slota, M., Lu, H., & Disis, M. L. (2025). A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer. Vaccines, 13(2), 117. https://doi.org/10.3390/vaccines13020117